Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;13(2):89-96.
doi: 10.12997/jla.2024.13.2.89. Epub 2023 Dec 7.

The Effect of Omega-3 Supplementation on Heart Failure Outcome: A Meta-Analysis of Randomized Clinical Trial

Affiliations
Review

The Effect of Omega-3 Supplementation on Heart Failure Outcome: A Meta-Analysis of Randomized Clinical Trial

Bambang Dwiputra et al. J Lipid Atheroscler. 2024 May.

Erratum in

  • Corrigendum to Previously Published Articles.
    Editorial Office of the Journal of Lipid and Atherosclerosis. Editorial Office of the Journal of Lipid and Atherosclerosis. J Lipid Atheroscler. 2025 Jan;14(1):132-133. doi: 10.12997/jla.2025.14.1.132. Epub 2025 Jan 14. J Lipid Atheroscler. 2025. PMID: 39911960 Free PMC article.

Abstract

The effect of omega-3 supplementation on cardiovascular (CV) disease has been widely studied in several large clinical trials. However, the evidence of the effect of omega-3 supplementation in patients with heart failure (HF) remains controversial. This meta-analysis investigated the effects of omega-3 supplementation on patients with HF. We conducted a literature search on MEDLINE, Embase, and Cochrane databases for clinical trials and preprints of relevant articles. Following a literature search and critical appraisal, 5 studies were included in the meta-analysis. The pooling of the result of the studies shows that there were no significant association between omega-3 supplementation and CV mortality (odds ratio [OR], 0.94; 95% confidence interval [CI], 0.84-1.05, p=0.16) nor hospitalization due to HF (OR, 0.94; 95% CI, 0.88-1.02; p=0.13). Our systematic review and meta-analysis showed that omega-3 supplementation has no beneficial effect in patients with HF.

Keywords: Atherosclerosis; Cardiovascular disease; Omega-3 fatty acid; Secondary prevention.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1. Mortality rate omega-3 compared with control.
GISSI-HF, Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure; ORIGIN, Outcome Reduction with an Initial Glargine Intervention; MH, Mantel-Haenszel; CI, confidence interval.
Fig. 2
Fig. 2. Hospitalization rate receiving omega 3 compared to control.
MH, Mantel-Haenszel; CI, confidence interval; GISSI-HF, Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure; ORIGIN, Outcome Reduction with an Initial Glargine Intervention; VITAL-HF, Vitamin D and Omega-3 Trial-Heart Failure.

References

    1. O’Keefe JH, Jr, Harris WS. From Inuit to implementation: omega-3 fatty acids come of age. Mayo Clin Proc. 2000;75:607–614. - PubMed
    1. Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380:11–22. - PubMed
    1. Risk and Prevention Study Collaborative Group. Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med. 2013;368:1800–1808. - PubMed
    1. Djoussé L, Cook NR, Kim E, Bodar V, Walter J, Bubes V, et al. Supplementation with vitamin D and omega-3 fatty acids and incidence of heart failure hospitalization: VITAL-Heart Failure. Circulation. 2020;141:784–786. - PMC - PubMed
    1. Mehra MR, Lavie CJ, Ventura HO, Milani RV. Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant. 2006;25:834–838. - PubMed